Beta-blocker after acute coronary syndrome: is it time to individualize therapy?

Back

EAPC Premium Access

Beta-blocker after acute coronary syndrome: is it time to individualize therapy?

Session: Young Investigator Award 1 - Population science and public health Section

Topic: Secondary Prevention

Speaker: Doctor P. Azevedo (Faro, PT)

Event: EuroPrevent 2019

Congress Presentation

Add to my library

About the speaker

Doctor Pedro Azevedo

Algarve University Hospital Center, Faro (Portugal)

0 follower

5 more presentations in this session

Urinary ethyl glucuronide as measure of alcohol consumption and cardiovascular disease: a population-based cohort study

Speaker: Ms I. van de Luitgaarden (Utrecht, NL)

Body mass index and blood pressure as predictors of cardiomegaly-associated line-of-duty sudden cardiac death in US firefighters: a case-control study

Speaker: Doctor M. Korre (Boston, US)

Epigenetic marker partially mediates the association between statin therapy and type 2 diabetes risk

Speaker: Ms C. Ochoa-Rosales (Rotterdam, NL)

Greater cardiorespiratory fitness reduces atrial fibrillation incidence: a meta-analysis

Speaker: Mr C. Verdicchio (Canberra, AU)

Access

Abstract

Arterial age and early vascular aging, but not chronological age, are associated with faster thoracic aortic aneurysm growth

Speaker: Doctor N. Santi (Ottawa, CA)

Access the full session

Young Investigator Award 1 - Population science and public health Section

Speakers: Doctor P. Azevedo, Ms I. van de Luitgaarden, Doctor M. Korre, Ms C. Ochoa-Rosales, Mr C. Verdicchio...

Access

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources